Monthly Archives: July 2020

Akebia Therapeutics Announces Approval of Vadadustat in Japan for the Treatment of Anemia Due to Chronic Kidney Disease in Dialysis-Dependent and Non-Dialysis Dependent Adult Patients

June 29, 2020 at 7:41 AM EDT First Regulatory Approval for Akebia’s HIF-PHI Marks Beginning of Next Phase of Akebia’s Growth Story CAMBRIDGE, Mass., June 29, 2020 /PRNewswire/ — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the … Continue reading

Posted in M Loghman-Adham, MD | Leave a comment